NCT06246461View on ClinicalTrials.gov

The Therapeutic Effect of Different Doses of Capecitabine

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

January 22, 2024

Conditions

Capecitabine

Interventions

DRUG

capecitabine

The control group was treated with 2,500 mg/m2 capecitabine, with 2,000 mg/m2 capecitabine for the medium-dose group and 1,500 mg/m2 capecitabine for the low-dose group.

Trial Locations (1)

214500

Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer, Jingjiang

All Listed Sponsors

lead

Jingjiang People's Hospital

OTHER

NCT06246461 - The Therapeutic Effect of Different Doses of Capecitabine | Biotech Hunter | Biotech Hunter